Phenprocoumon

Phenprocoumon

SCHEMBL3828265

CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O.O=C1c2ccccc2C(=O)C1c1ccccc1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

VKORC1

The experimentally established mechanism targets of Phenprocoumon. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
VKORC1 known ✓ Q9BQB6 3/20 0.58
CYP2C9 P11712 9/20 0.76
HSD17B10 Q99714 2/20 0.58
KDM4E B2RXH2 1/20 0.58
ALDH1A1 P00352 1/20 0.58
ALB P02768 1/20 0.58
PCSK7 Q16549 1/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
NQO1 P15559 2/20 0.56
CYP3A4 P08684 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenprocoumon SCHEMBL43031 0.87 CYP2C9 (1.00) CYP2C9VKORC1HSD17B10KDM4EALDH1A1
Phenprocoumon SCHEMBL24500477 0.87 CYP2C9 (1.00) CYP2C9VKORC1HSD17B10KDM4EALDH1A1
Phenprocoumon SCHEMBL29392123 0.87 CYP2C9 (1.00) CYP2C9VKORC1HSD17B10KDM4EALDH1A1
Phenprocoumon SCHEMBL24500472 0.87 CYP2C9 (1.00) CYP2C9VKORC1HSD17B10KDM4EALDH1A1
Ethyl Biscoumacetate SCHEMBL1900704 0.83 ADORA3 (0.76) CYP2C9VKORC1HSD17B10KDM4EALDH1A1
Warfarin SCHEMBL2762070 0.81 CYP2C9 (0.69) CYP2C9VKORC1HSD17B10KDM4EALDH1A1
SCHEMBL7351110 0.81 CYP2C9 (0.87) CYP2C9VKORC1HSD17B10KDM4EALDH1A1
SCHEMBL7350826 0.81 CYP2C9 (0.77) CYP2C9VKORC1HSD17B10KDM4EALDH1A1
SCHEMBL8042698 0.80 CYP2C9 (0.86) CYP2C9VKORC1HSD17B10KDM4EALDH1A1
SCHEMBL7348669 0.80 CYP2C9 (0.81) CYP2C9VKORC1HSD17B10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101777-A1 COMPOSITION FOR TREATING A PULMONARY HYPERTENSION Gilead Colorado, Inc. (US) 2009-09-23 EP disclosed
WO-2008073928-A1 COMPOSITION FOR TREATING A PULMONARY HYPERTENSION GILEAD COLORADO, INC. (US) 2008-06-19 WO disclosed